Role of viruses and bacteria-virus interactions in autoimmunity

Current Opinion in Immunology

Volumn 31, Issue , 2014, Pages 102-107

  Steed, Ashley L ^a   Stappenbeck, Thaddeus S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNE DISEASE; AUTOIMMUNITY; BACTERIA VIRUS INTERACTION; BACTERIAL INFECTION; CAUSAL ATTRIBUTION; COMMENSALISM; DISEASE ASSOCIATION; GENETIC SUSCEPTIBILITY; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; INNATE IMMUNITY; NONHUMAN; ORGANISMAL INTERACTION; REVIEW; VIRUS INFECTION; ANIMAL; AUTOIMMUNE DISEASES; BACTERIUM; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; MICROBIOLOGY; VIROLOGY; VIRUS;

ANIMALS; AUTOIMMUNE DISEASES; BACTERIA; BACTERIAL INFECTIONS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; VIRUS DISEASES; VIRUSES;

EID: 84908603104     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2014.10.006     Document Type: Review

References (68)

1. Selgrade M.K., Cooper G.S., Germolec D.R., Heindel J.J. Linking environmental agents and autoimmune disease: an agenda for future research. Environ Health Perspect 1999, 107(Suppl 5):811-813.
2. Fernando M.M., Stevens C.R., Walsh E.C., De Jager P.L., Goyette P., Plenge R.M., Vyse T.J., Rioux J.D. Defining the role of the MHC in autoimmunity: a review and pooled analysis. PLoS Genet 2008, 4:e1000024.
3. Cho J.H., Gregersen P.K. Genomics and the multifactorial nature of human autoimmune disease. N Engl J Med 2011, 365:1612-1623.
4. Bogdanos D.P., Smyk D.S., Rigopoulou E.I., Mytilinaiou M.G., Heneghan M.A., Selmi C., Gershwin M.E. Twin studies in autoimmune disease: genetics, gender and environment. J Autoimmun 2012, 38:J156-J169.
5. Javierre B.M., Hernando H., Ballestar E. Environmental triggers and epigenetic deregulation in autoimmune disease. Discov Med 2011, 12:535-545.
6. Munz C., Lunemann J.D., Getts M.T., Miller S.D. Antiviral immune responses: triggers of or triggered by autoimmunity?. Nat Rev Immunol 2009, 9:246-258.
7. Starr T.K., Jameson S.C., Hogquist K.A. Positive and negative selection of T cells. Annu Rev Immunol 2003, 21:139-176.
8. Klein L., Kyewski B., Allen P.M., Hogquist K.A. Positive and negative selection of the T cell repertoire: what thymocytes see (and don't see). Nat Rev Immunol 2014, 14:377-391.
9. Sakaguchi N., Takahashi T., Hata H., Nomura T., Tagami T., Yamazaki S., Sakihama T., Matsutani T., Negishi I., Nakatsuru S., et al. Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature 2003, 426:454-460.
10. Akirav E.M., Ruddle N.H., Herold K.C. The role of AIRE in human autoimmune disease. Nat Rev Endocrinol 2011, 7:25-33.
11. Giraud M., Yoshida H., Abramson J., Rahl P.B., Young R.A., Mathis D., Benoist C. Aire unleashes stalled RNA polymerase to induce ectopic gene expression in thymic epithelial cells. Proc Natl Acad Sci U S A 2012, 109:535-540.
12. Anderson M.S., Venanzi E.S., Klein L., Chen Z.B., Berzins S.P., Turley S.J., von Boehmer H., Bronson R., Dierich A., Benoist C., et al. Projection of an immunological self shadow within the thymus by the aire protein. Science 2002, 298:1395-1401.
13. Ramsey C., Winqvist O., Puhakka L., Halonen M., Moro A., Kampe O., Eskelin P., Pelto-Huikko M., Peltonen L. Aire deficient mice develop multiple features of APECED phenotype and show altered immune response. Hum Mol Genet 2002, 11:397-409.
14. Kuroda N., Mitani T., Takeda N., Ishimaru N., Arakaki R., Hayashi Y., Bando Y., Izumi K., Takahashi T., Nomura T., et al. Development of autoimmunity against transcriptionally unrepressed target antigen in the thymus of Aire-deficient mice. J Immunol 2005, 174:1862-1870.
15. Capalbo D., Giardino G., Martino L.D., Palamaro L., Romano R., Gallo V., Cirillo E., Salerno M., Pignata C. Genetic basis of altered central tolerance and autoimmune diseases: a lesson from AIRE mutations. Int Rev Immunol 2012, 31:344-362.
16. Bouneaud C., Kourilsky P., Bousso P. Impact of negative selection on the T cell repertoire reactive to a self-peptide: a large fraction of T cell clones escapes clonal deletion. Immunity 2000, 13:829-840.
17. Danke N.A., Koelle D.M., Yee C., Beheray S., Kwok W.W. Autoreactive T cells in healthy individuals. J Immunol 2004, 172:5967-5972.
18. Raddassi K., Kent S.C., Yang J., Bourcier K., Bradshaw E.M., Seyfert-Margolis V., Nepom G.T., Kwok W.W., Hafler D.A. Increased frequencies of myelin oligodendrocyte glycoprotein/MHC class II-binding CD4 cells in patients with multiple sclerosis. J Immunol 2011, 187:1039-1046.
19. Yang J., Danke N., Roti M., Huston L., Greenbaum C., Pihoker C., James E., Kwok W.W. CD4+ T cells from type 1 diabetic and healthy subjects exhibit different thresholds of activation to a naturally processed proinsulin epitope. J Autoimmun 2008, 31:30-41.
20. Maier L.M., Hafler D.A. Autoimmunity risk alleles in costimulation pathways. Immunol Rev 2009, 229:322-336.
21. Katoh H., Zheng P., Liu Y. FOXP3: genetic and epigenetic implications for autoimmunity. J Autoimmun 2013, 41:72-78.
22. Bedoya S.K., Lam B., Lau K., Larkin J. Th17 cells in immunity and autoimmunity. Clin Dev Immunol 2013, 2013:986789.
23. Liston A., Gray D.H. Homeostatic control of regulatory T cell diversity. Nat Rev Immunol 2014, 14:154-165.
24. Ganguly D., Haak S., Sisirak V., Reizis B. The role of dendritic cells in autoimmunity. Nat Rev Immunol 2013, 13:566-577.
25. Petukhova L., Duvic M., Hordinsky M., Norris D., Price V., Shimomura Y., Kim H., Singh P., Lee A., Chen W.V., et al. Genome-wide association study in alopecia areata implicates both innate and adaptive immunity. Nature 2010, 466:113-117.
26. Bai Y., Zhang Y., Yang Q., Hou Y., Hu N., Wang D., Sun H. The aberrant expression of stimulatory and inhibitory killer immunoglobulin-like receptors in NK- and NKT-cells contributes to lupus. Clin Lab 2014, 60:717-727.
27. Prakash S., Alam S., Bharadwaj U., Aggarwal A., Mishra R.N., Agrawal S. Associations of killer cell immunoglobulin like receptors with rheumatoid arthritis among North Indian population. Hum Immunol 2014, 75:802-807.
28. Lu L., Kim H.J., Werneck M.B., Cantor H. Regulation of CD8+ regulatory T cells: interruption of the NKG2A-Qa-1 interaction allows robust suppressive activity and resolution of autoimmune disease. Proc Natl Acad Sci U S A 2008, 105:19420-19425.
29. Tian Z., Gershwin M.E., Zhang C. Regulatory NK cells in autoimmune disease. J Autoimmun 2012, 39:206-215.
30. Brindley S.M., Lanham A.M., Karrer F.M., Tucker R.M., Fontenot A.P., Mack C.L. Cytomegalovirus-specific T-cell reactivity in biliary atresia at the time of diagnosis is associated with deficits in regulatory T cells. Hepatology 2012, 55:1130-1138.
31. Wang Y., Begum-Haque S., Telesford K.M., Ochoa-Reparaz J., Christy M., Kasper E.J., Kasper D.L., Robson S.C., Kasper L.H. A commensal bacterial product elicits and modulates migratory capacity of CD39 CD4 T regulatory subsets in the suppression of neuroinflammation. Gut Microbes 2014, 5:552-561.
32. Cunningham M.W. Streptococcus and rheumatic fever. Curr Opin Rheumatol 2012, 24:408-416.
33. Kambham N. Postinfectious glomerulonephritis. Adv Anat Pathol 2012, 19:338-347.
34. Nast C.C. Infection-related glomerulonephritis: changing demographics and outcomes. Adv Chronic Kidney Dis 2012, 19:68-75.
35. Jackson S.J., Steer A.C., Campbell H. Systematic review: estimation of global burden of non-suppurative sequelae of upper respiratory tract infection: rheumatic fever and post-streptococcal glomerulonephritis. Trop Med Int Health 2011, 16:2-11.
36. Tonietti G., Oldstone M.B., Dixon F.J. The effect of induced chronic viral infections on the immunologic diseases of New Zealand mice. J Exp Med 1970, 132:89-109.
37. Dyrberg T., Schwimmbeck P., Oldstone M. The incidence of diabetes in BB rats is decreased following acute LCMV infection. Adv Exp Med Biol 1988, 246:397-402.
38. Oldstone M.B. Prevention of type I diabetes in nonobese diabetic mice by virus infection. Science 1988, 239:500-502.
39. Wallberg M., Cooke A. Immune mechanisms in type 1 diabetes. Trends Immunol 2013, 34:583-591.
40. Hyoty H., Hiltunen M., Knip M., Laakkonen M., Vahasalo P., Karjalainen J., Koskela P., Roivainen M., Leinikki P., Hovi T., et al. A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes 1995, 44:652-657.
41. Yeung W.C., Rawlinson W.D., Craig M.E. Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies. BMJ 2011, 342:d35.
42. Ylipaasto P., Klingel K., Lindberg A.M., Otonkoski T., Kandolf R., Hovi T., Roivainen M. Enterovirus infection in human pancreatic islet cells, islet tropism in vivo and receptor involvement in cultured islet beta cells. Diabetologia 2004, 47:225-239.
43. Chatterjee N.K., Hou J., Dockstader P., Charbonneau T. Coxsackievirus B4 infection alters thymic, splenic, and peripheral lymphocyte repertoire preceding onset of hyperglycemia in mice. J Med Virol 1992, 38:124-131.
44. Brilot F., Geenen V., Hober D., Stoddart C.A. Coxsackievirus B4 infection of human fetal thymus cells. J Virol 2004, 78:9854-9861.
45. Smyth D.J., Cooper J.D., Bailey R., Field S., Burren O., Smink L.J., Guja C., Ionescu-Tirgoviste C., Widmer B., Dunger D.B., et al. A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat Genet 2006, 38:617-619.
46. Harkonen T., Lankinen H., Davydova B., Hovi T., Roivainen M. Enterovirus infection can induce immune responses that cross-react with beta-cell autoantigen tyrosine phosphatase IA-2/IAR. J Med Virol 2002, 66:340-350.
47. Wylie K.M., Mihindukulasuriya K.A., Zhou Y., Sodergren E., Storch G.A., Weinstock G.M. Metagenomic analysis of double-stranded DNA viruses in healthy adults. BMC Biol 2014, 12:71.
48. Virgin H.W., Wherry E.J., Ahmed R. Redefining chronic viral infection. Cell 2009, 138:30-50.
49. Draborg A.H., Duus K., Houen G. Epstein-Barr virus in systemic autoimmune diseases. Clin Dev Immunol 2013, 2013:535738.
50. Babcock G.J., Hochberg D., Thorley-Lawson A.D. The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell. Immunity 2000, 13:497-506.
51. Vergani D., Mieli-Vergani G. Autoimmune manifestations in viral hepatitis. Semin Immunopathol 2013, 35:73-85.
52. Cadwell K., Patel K.K., Maloney N.S., Liu T.C., Ng A.C., Storer C.E., Head R.D., Xavier R., Stappenbeck T.S., Virgin H.W. Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine. Cell 2010, 141:1135-1145.
53. Chervonsky A.V. Microbiota and autoimmunity. Cold Spring Harb Perspect Biol 2013, 5:a007294.
54. Blander J.M., Torchinsky M.B., Campisi L. Revisiting the old link between infection and autoimmune disease with commensals and T helper 17 cells. Immunol Res 2012, 54:50-68.
55. Kaur N., Chen C.C., Luther J., Kao J.Y. Intestinal dysbiosis in inflammatory bowel disease. Gut Microbes 2011, 2:211-216.
56. Takaishi H., Matsuki T., Nakazawa A., Takada T., Kado S., Asahara T., Kamada N., Sakuraba A., Yajima T., Higuchi H., et al. Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease. Int J Med Microbiol 2008, 298:463-472.
57. Willing B., Halfvarson J., Dicksved J., Rosenquist M., Jarnerot G., Engstrand L., Tysk C., Jansson J.K. Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease. Inflamm Bowel Dis 2009, 15:653-660.
58. Campieri M., Gionchetti P. Probiotics in inflammatory bowel disease: new insight to pathogenesis or a possible therapeutic alternative?. Gastroenterology 1999, 116:1246-1249.
59. Gevers D., Kugathasan S., Denson L.A., Vazquez-Baeza Y., Van Treuren W., Ren B., Schwager E., Knights D., Song S.J., Yassour M., et al. The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe 2014, 15:382-392.
60. Strober W., Fuss I.J., Blumberg R.S. The immunology of mucosal models of inflammation. Annu Rev Immunol 2002, 20:495-549.
61. Moon C., Stappenbeck T.S. Viral interactions with the host and microbiota in the intestine. Curr Opin Immunol 2012, 24:405-410.
62. Rakoff-Nahoum S., Hao L., Medzhitov R. Role of toll-like receptors in spontaneous commensal-dependent colitis. Immunity 2006, 25:319-329.
63. Bloom S.M., Bijanki V.N., Nava G.M., Sun L., Malvin N.P., Donermeyer D.L., Dunne W.M., Allen P.M., Stappenbeck T.S. Commensal bacteroides species induce colitis in host-genotype-specific fashion in a mouse model of inflammatory bowel disease. Cell Host Microbe 2011, 9:390-403.
64. Basic M., Keubler L.M., Buettner M., Achard M., Breves G., Schroder B., Smoczek A., Jorns A., Wedekind D., Zschemisch N.H., et al. Norovirus triggered microbiota-driven mucosal inflammation in interleukin 10-deficient mice. Inflamm Bowel Dis 2014, 20:431-443.
65. Abdollahi-Roodsaz S., Joosten L.A., Koenders M.I., Devesa I., Roelofs M.F., Radstake T.R., Heuvelmans-Jacobs M., Akira S., Nicklin M.J., Ribeiro-Dias F., et al. Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis. J Clin Invest 2008, 118:205-216.
66. Vaahtovuo J., Munukka E., Korkeamaki M., Luukkainen R., Toivanen P. Fecal microbiota in early rheumatoid arthritis. J Rheumatol 2008, 35:1500-1505.
67. Duerkop B.A., Clements C.V., Rollins D., Rodrigues J.L., Hooper L.V. A composite bacteriophage alters colonization by an intestinal commensal bacterium. Proc Natl Acad Sci U S A 2012, 109:17621-17626.
68. Perron H., Germi R., Bernard C., Garcia-Montojo M., Deluen C., Farinelli L., Faucard R., Veas F., Stefas I., Fabriek B.O., et al. Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis disease. Mult Scler 2012, 18:1721-1736.